These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2743321)

  • 1. Uptake and therapeutic effectiveness of 125I- and 211At-methylene blue for pigmented melanoma in an animal model system.
    Link EM; Brown I; Carpenter RN; Mitchell JS
    Cancer Res; 1989 Aug; 49(15):4332-7. PubMed ID: 2743321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases.
    Link EM; Carpenter RN
    Cancer Res; 1992 Aug; 52(16):4385-90. PubMed ID: 1643635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases.
    Link EM; Carpenter RN
    Cancer Res; 1990 May; 50(10):2963-7. PubMed ID: 2334899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [211At]methylene blue for targeted radiotherapy of human melanoma xenografts: dose fractionation in the treatment of cutaneous tumours.
    Link EM; Carpenter RN; Hansen G
    Eur J Cancer; 1996 Jun; 32A(7):1240-7. PubMed ID: 8758260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage.
    Link EM; Michalowski AS; Rösch F
    Eur J Cancer; 1996 Oct; 32A(11):1986-94. PubMed ID: 8943686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 211At-methylene blue in targeted radiotherapy of disseminated melanoma.
    Link EM; Michalowski AS; Rösch F
    Pigment Cell Res; 1994 Oct; 7(5):358-62. PubMed ID: 7886009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting melanoma with 211At/131I-methylene blue: preclinical and clinical experience.
    Link EM
    Hybridoma; 1999 Feb; 18(1):77-82. PubMed ID: 10211792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting disseminated melanoma with radiolabelled methylene blue: Comparative bio-distribution studies in man and animals.
    Link EM; Costa DC; Lui D; Ell PJ; Blower PJ; Spittle MF
    Acta Oncol; 1996; 35(3):331-41. PubMed ID: 8679265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary observations of malignant melanoma therapy using radiolabeled alpha-methyltyrosine.
    McLaughlin WH; Thramann WM; Lambrecht RM; Milius RA; Bloomer WD
    J Surg Oncol; 1988 Mar; 37(3):192-7. PubMed ID: 3352274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
    Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
    J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
    J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.
    Steffen AC; Almqvist Y; Chyan MK; Lundqvist H; Tolmachev V; Wilbur DS; Carlsson J
    Oncol Rep; 2007 May; 17(5):1141-7. PubMed ID: 17390057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative tissue distribution in mice of the alpha-emitter 211At and 131I as labels of a monoclonal antibody and F(ab')2 fragment.
    Garg PK; Harrison CL; Zalutsky MR
    Cancer Res; 1990 Jun; 50(12):3514-20. PubMed ID: 2340501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine and 211At-labeled guanidinomethyl halobenzoyl octreotate conjugates: potential peptide radiotherapeutics for somatostatin receptor-positive cancers.
    Vaidyanathan G; Boskovitz A; Shankar S; Zalutsky MR
    Peptides; 2004 Dec; 25(12):2087-97. PubMed ID: 15572196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
    Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steps towards cancer therapy with radionuclides--a review including radiation biophysical aspects.
    Kampf G
    Radiobiol Radiother (Berl); 1990; 31(3):215-29. PubMed ID: 2201055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted radiotherapy of pigmented melanoma with
    Xu X; Yuan L; Gai Y; Liu Q; Yin L; Jiang Y; Wang Y; Zhang Y; Lan X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):306. PubMed ID: 30537980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodinated methylene blue--a promising agent for melanoma scintigraphy: labelling, stability and in vitro uptake by melanoma cells.
    Sobal G; Rodrigues M; Sinzinger H
    Anticancer Res; 2008; 28(6A):3691-6. PubMed ID: 19189650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc(I)/Re(I) tricarbonyl complexes for in vivo targeting of melanotic melanoma: Synthesis and biological evaluation.
    Moura C; Gano L; Mendes F; Raposinho PD; Abrantes AM; Botelho MF; Santos I; Paulo A
    Eur J Med Chem; 2012 Apr; 50():350-60. PubMed ID: 22397924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.